Jessica Bylander
1981年收购SynOptics公司,开始进入内窥镜领域,随后几年迅速推出领先的内窥镜产品; 1985年开发出骨形态发生蛋白(OP-1); 1991-1997年陆续推出EndoSuite手术室、MPS3000手术床、救护车担架等重量级外科手术类产品; 1992年收购DIMSA公司,进入脊柱固定领域; 1996年收购Osteo公司,进入创伤领域。 中期(1997-2012)快速扩张期: ...
Food and Drug Administration (FDA) advisory committee to recommend that the agency not approve the premarketing approval (PMA) for Stryker's bone morphogenic protein, OP-1 Putty. A license agreement was signed between Stryker and Curis for the OP-line of products in December 2007. No specific ...
Regulatory-processResearch-and-developmentOsteogenic-protein-1, therapeutic useFracture, treatmentInpharma Weekly -doi:10.2165/00128413-200112760-00061NoneSpringer International PublishingInpharma Weekly
Orthopedics | Stryker Corporation announced in a press release that it has entered into a definitive agreement with Olympus Corporation for the sale of its OP-1 product family, which includes OP-1 Implant, OP-1 Putty, Opgenra and Osigraft, for use in orthopedic bone applications for ...
Orthopedics | Stryker Corporation announced yesterday the closing of the previously announced sale of its OP-1 product family, which includes OP-1 Implant, OP-1 Putty, Opgenra and Osigraft, for use in orthopedic bone applications to the Olympus Corporation. The transaction also include...
Stryker Wraps Up OP-1 Sale - Analyst BlogZacks Equity Research
Stryker to Jettison OP-1 for $60M - Analyst BlogZacks Equity Research
The Orthopaedic Implants segment sells orthopaedic reconstructive (hip, knee and shoulder), trauma, spinal and craniomaxillofacial implant systems; bone cement; and the bone growth factor OP-1. The MedSurg Equipment segment sells surgical equipment; surgical navigation systems; endoscopic, communications ...
The Orthopaedic Implants segment sells orthopaedic reconstructive (hip, knee and shoulder), trauma, spinal and craniomaxillofacial implant systems; bone cement; and the bone growth factor OP-1. The MedSurg Equipment segment sells surgical equipment; surgical navigation systems; endoscopic, communications ...